...
首页> 外文期刊>Bioorganic and medicinal chemistry >Synthesis and evaluation of 4-(2-fluoro-4-[C-11]methoxyphenyl)-5-((2-methylpyridin-4-yl)methoxy)picolinamide for PET imaging of the metabotropic glutamate receptor 2 in the rat brain
【24h】

Synthesis and evaluation of 4-(2-fluoro-4-[C-11]methoxyphenyl)-5-((2-methylpyridin-4-yl)methoxy)picolinamide for PET imaging of the metabotropic glutamate receptor 2 in the rat brain

机译:4-(2-氟-4- [C-11]甲氧基苯基)-5 - ((2-甲基吡啶-4-基)甲氧基)吡啶胺的合成与评价,用于大鼠脑中代表胞罗谷氨酸受体2的PET成像

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Metabotropic glutamate receptor 2 (mGluR2) has been suggested as a therapeutic target for treating schizophrenia-like symptoms arising from increased glutamate transmission in the human forebrain. However, no reliable positron emission tomography (PET) radiotracer allowing for in vivo visualization of mGluR2 in the human brain is currently available. In this study, we synthesized 4-(2-fluoro-4-[C-11] methoxyphenyl)-5-((2-methylpyridin-4-yl)methoxy)picolinamide ([C-11]1) and evaluated its potential as a PET tracer for imaging mGluR2 in the rodent brain. Compound 1, a negative allosteric modulator (NAM) of mGluR2, showed high in vitro binding affinity (IC50: 26 nM) for mGluR2 overexpressed in human cells. [C-11]1 was synthesized by O-[C-11]methylation of the phenol precursor 2 with [C-11] methyl iodide. After the reaction, HPLC purification and formulation, [C-11]1 of 7.4 +/- 2.8 GBq (n=8) was obtained from [C-11] carbon dioxide of 22.5 +/- 4.8 GBq (n=8) with > 99% radiochemical purity and 70 +/- 32 GBq/mu mol (n=8) molar activity at the end of synthesis. In vitro autoradiography for rat brains showed that [C-11]1 binding was heterogeneously distributed in the cerebral cortex, striatum, hippocampus, and cerebellum. This pattern is consistent with the regional distribution pattern of mGluR2 in the rodent brain. The radioactivity was significantly reduced by self-or MNI-137 (a mGluR2 NAM) blocking. Small-animal PET studies indicated a low in vivo specific binding of [C-11]1 in the rat brain. The brain uptake was increased in a P-glycoprotein and breast cancer resistant protein double knockout mouse, when compared to a wild-type mouse. While [C-11]1 presented limited potential as an in vivo PET tracer for mGluR2, we suggested that it can be used as a lead compound for developing new radiotracers with improved in vivo brain properties.
机译:已经提出了代谢谷氨酸受体2(MGLUR2)作为治疗从人前脑中增加的谷氨酸透射率产生的精神分裂症样症状的治疗靶标。然而,目前没有任何可靠的正电子发射断层扫描(PET)放射性机构目前可获得人脑体内MGLUR2的体内可视化。在该研究中,我们合成了4-(2-氟-4- [C-11]甲氧基苯基)-5-((2-甲基吡啶-4-基)甲氧基)吡啶胺([C-11] 1)并评估其潜力作为用于在啮齿动物大脑中成像mglur2的宠物示踪剂。化合物1,MgLuR2的负变性调节剂(NAM),显示出在人细胞中过表达的MGLUR2的高体外结合亲和力(IC50:26nm)。通过用[C-11]甲基碘的苯酚前体2的甲基化合成[C-11] 1。反应后,HPLC纯化和制剂,[C-11] 1的7.4 +/- 2.8GBQ(n = 8),得到22.5 +/- 4.8 gbq(n = 8)的二氧化碳(n = 8)在合成结束时> 99%放射化学纯度和70 +/- 32个GBQ / mu mol(n = 8)摩尔活性。对大鼠大脑的体外放射造影显示[C-11] 1结合在脑皮质,纹状体,海马和小脑中是异质的分布。这种模式与啮齿动物大脑中Mglur2的区域分布模式一致。通过自我或MNI-137(MGLUR2 NAM)阻断显着降低放射性。小动物宠物研究表明,大鼠脑中[C-11] 1的体内特异性结合低。与野生型小鼠相比,在P-糖蛋白和乳腺癌抗性蛋白双敲除小鼠中脑吸收增加。虽然[C-11] 1呈现为MGLUR2的体内PET示踪剂的有限潜力,我们建议它可以用作开发新的患者的铅化合物,以改善体内脑性质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号